John R. Mehall: The Importance of Anticoagulation Management in ECMO
John R. Mehall, President of Integration Health, Senior Vice President of Heart and Vascular Partners, Co-Founder of Pacific Tarn Capital, Advanced CV Fellow at HaloDx, shared Neil Honey‘s post on LinkedIn:
“Anticoagulation management is a critical skill in ECMO.
When done well, it can extend the life of circuits and oxygenators, reducing the risk of changing them and saving money.”
Neil Honey, Director of Partnerships and Digital Marketing at Integration Health, Realtor at Kerr and Co. Realty, shared a post on LinkedIn:
“TEG in ECMO: Are you using it in your program?
Integration Health‘s August newsletter takes a closer look at thromboelastography testing and how real-time assessment of hemostasis can help inform clinical decision-making throughout the patient’s ECMO course.
But we want to hear from the people actually at the bedside:
Is your ECMO program using TEG?
- If so, how are you incorporating it into your practice?
- If not, what’s holding your program back?
Join the conversation and tell us what you’re seeing in your program.”
Stay updated with Hemostasis Today.
-
Oct 21, 2026, 16:57Fabrice Cognasse: Celebrating the Next Generation of Platelet Research and Transfusion Medicine
-
Oct 21, 2026, 16:47Christabel Odeta: Treating Pediatric Cancer in Children With Sickle Cell Disease
-
Oct 21, 2026, 16:36Sharlene Haywood: Bringing Multidisciplinary Learning Into Nursing Practice
-
Oct 21, 2026, 16:19Vanessa Carvalho: New Research on Platelet-Derived Extracellular Vesicles in Preeclampsia
-
Oct 21, 2026, 15:41Women and Hemostasis Across Hormonal Transition
-
Oct 21, 2026, 15:35Danny Hsu: Pharma’s 2025 Blockbusters Through a Hematologist’s Lens
-
Oct 21, 2026, 15:12Yue Zhang: Flow Cytometry for Translational Immunology and Cancer Research
-
Oct 21, 2026, 14:58Radoš Stefanović: How Red Blood Cells Adapt After Exercise
-
Oct 21, 2026, 14:08Vera Ghali: The Role of Hepcidin Assays in Diagnosing Iron Disorders